NCT06973434Completed
Comparison of Video and Direct Laryngoscopy in Obese Patients During Surgery
"Effects of Conventional and Video Laryngoscopy Methods on VIDIAC Scores and Hemodynamic Stability in Obese Patients: Comparison of Storz C-MAC3, Scoper MAC-3 and Macintosh"
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
This study aims to evaluate how intubation performed with two different brands of videolaryngoscope and the Macintosh laryngoscope during surgeries in obese patients requiring general anesthesia affects the VIDIAC score, hemodynamic response, and early postoperative complications. Complications such as sore throat, hoarseness, nausea, and vomiting will be recorded in the recovery room prior to discharge.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 135 (actual)
- First submitted
- 10 Apr 2025
- Start date
- 1 May 2025
- Primary completion date
- 30 Nov 2025
- Lead sponsor
- Harran University
- Diseases
- Obesity
- NCT number
- NCT06973434
What you commit to
- Study type: Observational
- Participants enrolled: 135
- From 1 May 2025 to the primary completion date, 30 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Emergency surgery indication
Other illness
- Advanced cardiopulmonary disease
Other
- Refusal to participate in the study
- ASA physical status III, IV, or V
- Cervical spine movement limitation
- Pregnancy
- Coagulopathy
- Known or anticipated difficult airway
- Severe anatomical deformity of the airway
Who the study is looking for
- Age between 18 and 65 years
- Body mass index (BMI) ≥30 kg/m²
- ASA physical status I or II
- Scheduled for elective surgery
- Requiring endotracheal intubation
- Provided written informed consent
Age in the registry: 18 years to 65 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Veli Fahri Pehlivan Coordinator of this site? Confirm its status | Sanliurfa | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.